Proscia
Rewiring pathology for precision medicine
- Headquarters
- Philadelphia, Pennsylvania
- Employees
- 51–200
- Founded
- 2014
- Business Model
- B2B
- Website
- proscia.com
- Total Funding
- $118.3M
- Last Round
- $50.0M Series CMar 2025
About
Proscia is a Philadelphia-based digital pathology software company founded in 2014 by David West, Coleman Stavish, and Nathan Buchbinder. The company's Concentriq platform is an enterprise digital pathology system used by more than 12,000 pathologists and scientists daily at reference labs, academic medical centers, CROs, and 16 of the top 20 global pharma companies. Concentriq offers purpose-built products for life sciences research, anatomic pathology digitization, and FDA-cleared primary diagnosis. Proscia also offers Aperture, a precision medicine solution for drug development and real-world evidence generation.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account